Alex Goldberg

NYSE Active Stock Watch List: Omnicare Inc. (NYSE:OCR) and Vale S.A. (NYSE:VALE) Added to Equity Profile Report's NYSE Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/20/2014 -- Equity Profile Report expands its NYSE Active Stock Weekly Watch List adding Omnicare Inc. (NYSE:OCR) and Vale S.A. (NYSE:VALE).

Omnicare Inc. (NYSE:OCR) operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada closed down in its previous session (-5.52%) on 5,832,238 shares traded after Omnicare Reported Fourth-Quarter and Full-Year 2013 Financial Results. Omnicare Inc. (NYSE:OCR) is currently down (-8.65%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.

Click Here to find out what other Investors are saying about Omnicare Inc. (NYSE:OCR)

Vale S.A. (NYSE:VALE) a company that engages in the research, production, and marketing of iron ore and pellets, nickel, fertilizers, copper, coal, manganese, ferroalloys, cobalt, platinum group metals, and precious metals in Brazil and internationally closed up in its previous session (+1.11%) on 21,459,071 shares traded. Vale S.A. (NYSE:VALE) is currently up (+18.72%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.

Click Here to find out what other Investors are saying about Vale S.A. (NYSE:VALE)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com